Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 190395, 18 pages
http://dx.doi.org/10.1155/2013/190395
Research Article

Stress and Its Effects on Glucose Metabolism and 11 -HSD Activities in Rats Fed on a Combination of High-Fat and High-Sucrose Diet with Glycyrrhizic Acid

Monash University Sunway Campus, Jalan Lagoon Selatan, Bandar Sunway, 46150 Selangor Darul Ehsan, Malaysia

Received 20 December 2012; Accepted 29 January 2013

Academic Editor: Gordana Kocic

Copyright © 2013 Hamish Alexander Fernando et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Panchal, H. Poudyal, A. Iyer et al., “High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats,” Journal of Cardiovascular Pharmacology, vol. 57, no. 1, pp. 51–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Stinnett and A. F. Seasholtz, “Stress and emotionality,” in Encyclopedia of Behavioral Neuroscience, G. F. Koob, M. Le Moal, and R. F. Thompson, Eds., pp. 316–321, Elsevier, 2010. View at Google Scholar
  5. B. H. Ruszymah and B. A. Khalid, “A survey of recent results concerning glycyrrhizic acid in stress and adaptation,” Medical Journal of Islamic Academy of Sciences, vol. 12, no. 1, pp. 25–28, 1999. View at Google Scholar
  6. P. Sterling and J. Eyer, “Allostasis: a new paradigm to explain arousal pathology,” in Handbook of Life Stress, Cognition and Health, S. Fisher and J. Reason, Eds., pp. 631–651, John Wiley & Sons, New York, NY, USA, 1988. View at Google Scholar
  7. P. Björntorp, “Do stress reactions cause abdominal obesity and comorbidities?” Obesity Reviews, vol. 2, no. 2, pp. 73–86, 2001. View at Google Scholar · View at Scopus
  8. G. P. Chrousos and P. W. Gold, “The inhibited child "syndrome". Thoughts on its potential pathogenesis and sequelae,” in Extreme Fear, Shyness and Social Phobia: Origins, Biological Mechanisms and Clinical Outcomes, L. A. Schmidt and J. Schulkin, Eds., pp. 193–200, Informa Healthcare, Stockholm, Sweden, 1999. View at Google Scholar
  9. P. Pervanidou and G. P. Chrousos, “Post-traumatic stress disorder in children and adolescents: from Sigmund Freud's "Trauma" to psychopathology and the (Dys)metabolic syndrome,” Hormone and Metabolic Research, vol. 39, no. 6, pp. 413–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Rosmond, “Role of stress in the pathogenesis of the metabolic syndrome,” Psychoneuroendocrinology, vol. 30, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Björntorp, “Body fat distribution, insulin resistance, and metabolic diseases,” Nutrition, vol. 13, no. 9, pp. 795–803, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Tomlinson, E. A. Walker, I. J. Bujalska et al., “11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response,” Endocrine Reviews, vol. 25, no. 5, pp. 831–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Ploeger, T. Mensinga, A. Sips, W. Seinen, J. Meulenbelt, and J. DeJongh, “The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling,” Drug Metabolism Reviews, vol. 33, no. 2, pp. 125–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Peckett, D. C. Wright, and M. C. Riddell, “The effects of glucocorticoids on adipose tissue on lipid metabolism,” Metabolism Clinical and Experimental, vol. 60, pp. 1500–1510, 2011. View at Google Scholar
  15. F. S. Schlingmann, H. L. De Rijk, W. J. Pereboom, and R. Remie, “Avoidance as a behavioural parameter in the determination of distress amongst albino and pigmented rats at various light intensities,” Animal Technology, vol. 44, no. 2, pp. 87–96, 1993. View at Google Scholar
  16. L. J. M. Vanderschuren, R. J. M. Niesink, B. M. Spruijt, and J. M. Van Ree, “Influence of environmental factors on social play behavior of juvenile rats,” Physiology and Behavior, vol. 58, no. 1, pp. 119–123, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Matsuo and K. Tsuji, “Strain differences of the light-dark preference in inbred rats,” Behavior Genetics, vol. 19, no. 3, pp. 457–466, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Williams, A. G. Howard, and T. P. Williams, “Retinal damage in pigmented and albino rats exposed to low levels of cyclic light following a single mydriatic treatment,” Current Eye Research, vol. 4, no. 2, pp. 97–102, 1985. View at Google Scholar · View at Scopus
  19. M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy, “Prolactin: structure, function and regulation of secretion,” Physiology Reviews, vol. 80, pp. 1523–1621, 2000. View at Google Scholar
  20. M. A. Wong and S. M. Oace, “Feeding pattern and gastrointestinal transit rate of rats under different room lighting schedules,” Laboratory Animal Science, vol. 31, no. 4, pp. 362–365, 1981. View at Google Scholar · View at Scopus
  21. D. L. McEachron, K. M. Tumas, K. J. Blank, and M. B. Prystowsky, “Environmental lighting alters the infection process in an animal model of AIDS,” Pharmacology Biochemistry and Behavior, vol. 51, no. 4, pp. 947–952, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. C. A. Blake, “Effects of pinealectomy on the rat oestrous cycle and pituitary gonadotrophin release,” Journal of Endocrinology, vol. 69, no. 1, pp. 67–75, 1976. View at Google Scholar · View at Scopus
  23. R. T. Dauchy, L. A. Sauer, D. E. Blask, and G. M. Vaughan, “Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats,” Laboratory Animal Science, vol. 47, no. 5, pp. 511–518, 1997. View at Google Scholar · View at Scopus
  24. C. Chandramouli, S. T. Yong, Y. L. Lam, S. H. Ton, and B. A. Khalid, “Glycyrrhizic acid improves lipid and glucose metabolism in high-sucrose-fed rats,” Journal of Endocrinology and Metabolism, vol. 1, no. 3, pp. 125–141, 2011. View at Google Scholar
  25. C. H. A. Eu, W. Y. A. Lim, S. H. Ton, and B. A. Khalid, “Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats,” Lipids in Health and Disease, vol. 9, article 81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Esler, G. Jackman, A. Bobik et al., “Determination of norepinephrine apparent release rate and clearance in humans,” Life Sciences, vol. 25, no. 17, pp. 1461–1470, 1979. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Venkataraman, R. Munoz, C. Candido, and S. F. Witchel, “The hypothalamic-pituitary-adrenal axis in critical illness,” Reviews in Endocrine and Metabolic Disorders, vol. 8, no. 4, pp. 365–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Ainsah, B. M. Nabishah, C. B. Osman, and B. A. K. Khalid, “Effects of naloxone, glycyrrhizic acid, dexamethasone and deoxycorticosterone in repetitive stress,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 5-6, pp. 433–437, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Ainsah, B. M. Nabishah, C. B. Osman, and B. A. K. Khalid, “Short- and long-term effects of glycyrrhizic acid in repetitive stress,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 5-6, pp. 444–448, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. E. Altuna, S. M. Lelli, L. C. San Martín De Viale, and M. C. Damasco, “Effect of stress on hepatic 11β-hydroxysteroid dehydrogenase activity and its influence on carbohydrate metabolism,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 10, pp. 977–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. H. Farihah, B. M. Nabishah, and B. A. Khalid, “Isoprenaline reverses glycyrrhizic acid—induced inhibition of 11-hydroxysteroid dehydrogenase bioactivity,” Pakistan Journal of Nutrition, vol. 5, no. 6, pp. 544–547, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Lichtenstein, M. J. Shipley, and G. Rose, “Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study,” British Medical Journal, vol. 291, no. 6490, pp. 243–245, 1985. View at Google Scholar · View at Scopus
  33. W. W. Dressler, “Modernization, stress, and blood pressure: new directions in research,” Human Biology, vol. 71, no. 4, pp. 583–605, 1999. View at Google Scholar · View at Scopus
  34. S. H. M. Van Uum, A. R. M. M. Hermus, P. Smits, T. Thien, and J. W. M. Lenders, “The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension,” Cardiovascular Research, vol. 38, no. 1, pp. 16–24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Pauline, S. T. Avadhany, and K. N. Maruthy, “Non invasive measurement of systolic blood pressure in rats: a simple technique,” Al Ameen Journal of Medical Science, vol. 4, no. 4, pp. 365–369, 2011. View at Google Scholar
  36. P. Depres-Brummer, F. Levi, G. Metzger, and Y. Touitou, “Light-induced suppression of the rat circadian system,” American Journal of Physiology, vol. 268, no. 5, pp. R1111–R1116, 1995. View at Google Scholar · View at Scopus
  37. J. Vilaplana, T. Cambras, and A. Diez-Noguera, “Effects of light intensity on the activity rhythm of young rats,” Biological Rhythm Research, vol. 26, no. 3, pp. 306–315, 1995. View at Google Scholar
  38. K. Witte and B. Lemmer, “Free-running rhythms in blood pressure, heart rate, and motor activity in normotensive and transgenic hypertensive rats,” Chronobiology International, vol. 12, pp. 237–247, 1995. View at Google Scholar
  39. W. Witting, D. Boerma, G. C. Koster-Van Hoffen, D. F. Swaab, and M. Mirmiran, “Light suppresses frequency and endogenous amplitude of the circadian system in nocturnal animals,” Biological Rhythm Research, vol. 26, no. 5, pp. 477–485, 1995. View at Google Scholar · View at Scopus
  40. S. A. Briaud, B. L. Zhang, and F. Sannajust, “Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 9, no. 2, pp. 97–105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Pandi-Perumal, V. Srinivasan, G. J. M. Maestroni, D. P. Cardinali, B. Poeggeler, and R. Hardeland, “Melatonin: nature's most versatile biological signal?” FEBS Journal, vol. 273, no. 13, pp. 2813–2838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Zanoboni and W. Zanoboni-Muciaccia, “Experimental hypertension in pinealectomized rats,” Life Sciences, vol. 6, no. 21, pp. 2327–2331, 1967. View at Google Scholar · View at Scopus
  43. R. V. Gallara, S. L. Bellavia, L. L. Serova, and E. L. Sabban, “Environmental light conditions alter gene expression of rat catecholamine biosynthetic enzymes and Neuropeptide Y: differential effect in superior cervical ganglia and adrenal gland,” Molecular Brain Research, vol. 124, no. 2, pp. 152–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Morimoto, T. Watanabe, K. Morimoto, T. Nakamori, and N. Murakami, “Possible involvement of prostaglandins in psychological stress-induced responses in rats,” Journal of Physiology, vol. 443, pp. 421–429, 1991. View at Google Scholar · View at Scopus
  45. D. E. Handy, C. Johns, M. R. Bresnahan, A. Tavares, M. Bursztyn, and H. Gavras, “Expression of α2-adrenergic receptors in normal and atherosclerotic rabbit aorta,” Hypertension, vol. 32, no. 2, pp. 311–317, 1998. View at Google Scholar · View at Scopus
  46. R. Kvetnansky, K. Fukuhara, K. Pacak, G. Cizza, D. S. Goldstein, and I. J. Kopin, “Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats,” Endocrinology, vol. 133, no. 3, pp. 1411–1419, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. R. C. Andrews, O. Rooyackers, and B. R. Walker, “Effects of the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 1, pp. 285–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Cassuto, K. Kochan, K. Chakravarty et al., “Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit,” The Journal of Biological Chemistry, vol. 280, no. 40, pp. 33873–33884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Vegiopoulos and S. Herzig, “Glucocorticoids, metabolism and metabolic diseases,” Molecular and Cellular Endocrinology, vol. 275, no. 1-2, pp. 43–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Barth, G. Albuszies, K. Baumgart et al., “Glucose metabolism and catecholamines,” Critical Care Medicine, vol. 35, no. 9, pp. S508–S518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Niijima, K. Nagai, N. Nagai, and H. Nakagawa, “Light enhances sympathetic and suppresses vagal outflows and lesions including the suprachiasmatic nucleus eliminate these changes in rats,” Journal of the Autonomic Nervous System, vol. 40, no. 2, pp. 155–160, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Alberts, C. Nilsson, G. Selén et al., “Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains,” Endocrinology, vol. 144, no. 11, pp. 4755–4762, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. H. I. Kim and Y. H. Ahn, “Role of peroxisome proliferator-activated receptor-γ in the glucose-sensing apparatus of liver and β-cells,” Diabetes, vol. 53, supplement 1, pp. S60–S65, 2004. View at Google Scholar · View at Scopus
  55. Z. K. Xu, N. G. Chen, C. Y. Ma, Z. X. Meng, Y. J. Sun, and X. Han, “Role of peroxisome proliferator-activated receptor gamma in glucose-induced insulin secretion,” Acta Biochimica et Biophysica Sinica, vol. 38, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Burén, S. A. Bergström, E. Loh, I. Söderström, T. Olsson, and C. Mattsson, “Hippocampal 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese zucker rat,” Endocrinology, vol. 148, no. 6, pp. 2716–2722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Van den Berghe, “The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism,” Journal of Inherited Metabolic Disease, vol. 14, no. 4, pp. 407–420, 1991. View at Google Scholar · View at Scopus
  58. J. R. Seckl and B. R. Walker, “Minireview: 11β-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action,” Endocrinology, vol. 142, no. 4, pp. 1371–1376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Khani and J. A. Tayek, “Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome,” Clinical Science, vol. 101, no. 6, pp. 739–747, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. R. W. Brown, K. E. Chapman, C. R. W. Edwards, and J. R. Seckl, “Human placental 11β-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform,” Endocrinology, vol. 132, no. 6, pp. 2614–2621, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. P. M. Jamieson, K. E. Chapman, and J. R. Seckl, “Tissue- and temporal-specific regulation of 11β-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo,” Journal of Steroid Biochemistry and Molecular Biology, vol. 68, no. 5-6, pp. 245–250, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. S. H. Farihah, B. M. Nabishah, and B. A. Khalid, “Effect of corticosteroids and glycyrrhizic acid on the bioactivity of 11B-hydroxysteroid dehydrogenase in repetitive stress,” in Proceedings of the 11th International Congress of Endocrinology, p. 76, 2000.
  63. L. Paternain, D. F. García-Diaz, F. I. Milagro, P. González-Muniesa, J. A. Martinez, and J. Campión, “Regulation by chronic-mild stress of glucocorticoids, monocyte chemoattractant protein-1 and adiposity in rats fed on a high-fat diet,” Physiology and Behavior, vol. 103, no. 2, pp. 173–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Gong, D. J. Morris, and A. S. Brem, “Variable expression of 11β Hydroxysteroid dehydrogenase (11β-HSD) isoforms in vascular endothelial cells,” Steroids, vol. 73, no. 11, pp. 1187–1196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Tsugita, Y. Iwasaki, M. Nishiyama et al., “Differential regulation of 11β-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells,” Life Sciences, vol. 83, no. 11-12, pp. 426–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. B. L. Roland, Z. S. Krozowski, and J. W. Funder, “Glucocorticoid receptor, mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies,” Molecular and Cellular Endocrinology, vol. 111, no. 1, pp. R1–R7, 1995. View at Publisher · View at Google Scholar · View at Scopus
  67. W. H. Elliot and D. C. Elliot, Biochemistry and Molecular Biology, Oxford University Press, Oxford, UK, 3rd edition, 2005.
  68. C. Meyer, M. Stumvoll, V. Nadkarni, J. Dostou, A. Mitrakou, and J. Gerich, “Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus,” Journal of Clinical Investigation, vol. 102, no. 3, pp. 619–624, 1998. View at Google Scholar · View at Scopus
  69. M. Quinkler, H. Troeger, E. Eigendorff et al., “Enhanced 11β-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig,” Journal of Endocrinology, vol. 176, no. 2, pp. 185–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. D. E. W. Livingstone, G. C. Jones, K. Smith et al., “Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats,” Endocrinology, vol. 141, no. 2, pp. 560–563, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. A. L. Albiston, V. R. Obeyesekere, R. E. Smith, and Z. S. Krozowski, “Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme,” Molecular and Cellular Endocrinology, vol. 105, no. 2, pp. R11–R17, 1994. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Rusvai and A. Naray-Fejes-Toth, “A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells,” The Journal of Biological Chemistry, vol. 268, no. 15, pp. 10717–10720, 1993. View at Google Scholar · View at Scopus
  73. P. M. Stewart, C. B. Whorwood, and J. I. Mason, “Type 2 11β-hydroxysteroid dehydrogenase in foetal and adult life,” Journal of Steroid Biochemistry and Molecular Biology, vol. 55, no. 5-6, pp. 465–471, 1995. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Diederich, M. Quinkler, K. Miller, P. Heilmann, M. Schöneshöfer, and W. Oelkers, “Human kidney 11β-hydroxy steroid dehydrogenase: regulation by adrenocorticotropin?” European Journal of Endocrinology, vol. 134, no. 3, pp. 301–307, 1996. View at Google Scholar · View at Scopus
  75. M. Quinkler, S. Johanssen, C. Großmann et al., “Progesterone metabolism in the human kidney and inhibition of 11β-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites,” The Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 11, pp. 4165–4171, 1999. View at Google Scholar · View at Scopus
  76. G. Frühbeck, J. Gómez-Ambrosi, F. J. Muruzábal, and M. A. Burrell, “The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation,” American Journal of Physiology, vol. 280, no. 6, pp. E827–E847, 2001. View at Google Scholar · View at Scopus
  77. T. Ronti, G. Lupattelli, and E. Mannarino, “The endocrine function of adipose tissue: an update,” Clinical Endocrinology, vol. 64, no. 4, pp. 355–365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. J. E. Campbell, A. J. Peckett, A. M. D'Souza, T. J. Hawke, and M. C. Riddell, “Adipogenic and lipolytic effects of chronic glucocorticoid exposure,” American Journal of Physiology, vol. 300, no. 1, pp. C198–C209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. J. N. Fain and R. Saperstein, “The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids,” Hormone and Metabolic Research, vol. 2, pp. 2–27, 1970. View at Google Scholar · View at Scopus
  80. B. G. Slavin, J. M. Ong, and P. A. Kern, “Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes,” Journal of Lipid Research, vol. 35, no. 9, pp. 1535–1541, 1994. View at Google Scholar · View at Scopus
  81. C. Xu, J. He, H. Jiang et al., “Direct effect of glucocorticoids on lipolysis in adipocytes,” Molecular Endocrinology, vol. 23, no. 8, pp. 1161–1170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. I. J. Bujalska, S. Kumar, M. Hewison, and P. M. Stewart, “Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase,” Endocrinology, vol. 140, no. 7, pp. 3188–3196, 1999. View at Google Scholar · View at Scopus
  83. B. Appel and S. K. Fried, “Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue,” American Journal of Physiology, vol. 262, no. 5, part 1, pp. E695–E699, 1992. View at Google Scholar · View at Scopus
  84. S. K. Fried, C. D. Russell, N. L. Grauso, and R. E. Brolin, “Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men,” Journal of Clinical Investigation, vol. 92, no. 5, pp. 2191–2198, 1993. View at Google Scholar · View at Scopus
  85. A. M. Strack, R. J. Sebastian, M. W. Schwartz, and M. F. Dallman, “Glucocorticoids and insulin: reciprocal signals for energy balance,” American Journal of Physiology, vol. 268, no. 1, part 2, pp. R142–R149, 1995. View at Google Scholar · View at Scopus
  86. I. Lee, Y. Chiu, C. Hwu et al., “Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort,” Cardiovascular Diabetology, vol. 11, article 43, 2012. View at Google Scholar
  87. I. J. Bujalska, L. L. Gathercole, J. W. Tomlinson et al., “A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis,” Journal of Endocrinology, vol. 197, no. 2, pp. 297–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker, “Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue,” Recent Progress in Hormone Research, vol. 59, pp. 359–393, 2004. View at Google Scholar · View at Scopus
  89. S. Talbott, The Cortisol Connection: Why Stress Makes You Fat and Ruins Your Health—and What You Can Do About It, Hunter House, 2007.
  90. S. Engeli, J. Böhnke, M. Feldpausch et al., “Regulation of 11β-HSD genes in human adipose tissue: influence of central obesity and weight loss,” Obesity Research, vol. 12, no. 1, pp. 9–17, 2004. View at Google Scholar · View at Scopus
  91. A. D. Baron, G. Brechtel, P. Wallace, and S. V. Edelman, “Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans,” American Journal of Physiology, vol. 255, no. 6, part 2, pp. E769–E774, 1988. View at Google Scholar · View at Scopus
  92. C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I. Phillips, and C. D. Byrne, “Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome,” Diabetes, vol. 51, no. 4, pp. 1066–1075, 2002. View at Google Scholar · View at Scopus
  93. S. A. Morgan, M. Sherlock, L. L. Gathercole et al., “11β-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid- induced insulin resistance in skeletal muscle,” Diabetes, vol. 58, no. 11, pp. 2506–2515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Ruzzin, A. S. Wagman, and J. Jensen, “Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor,” Diabetologia, vol. 48, no. 10, pp. 2119–2130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Jang, V. R. Obeyesekere, F. P. Alford, and W. J. Inder, “Skeletal muscle 11β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery,” European Journal of Endocrinology, vol. 160, no. 2, pp. 249–255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Dovio, E. Roveda, C. Sciolla et al., “Intense physical exercise increases systemic 11β-hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects,” European Journal of Applied Physiology, vol. 108, no. 4, pp. 681–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. L. L. Chen, X. Hu, J. Zheng et al., “Increases in energy intake, insulin resistance and stress in rats before Wenchuan earthquake far from the epicenter,” Experimental Biology and Medicine, vol. 235, no. 10, pp. 1216–1223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. A. E. Coutinho, J. E. Campbell, S. Fediuc, and M. C. Riddell, “Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11β-HSD1 in the Syrian hamster,” Journal of Applied Physiology, vol. 100, no. 5, pp. 1483–1488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. L. B. Borghouts and H. A. Keizer, “Exercise and insulin sensitivity: a review,” International Journal of Sports Medicine, vol. 21, no. 1, pp. 1–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Benrick, V. Wallenius, and I. W. Asterholm, “Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice,” Experimental Physiology, vol. 97, no. 11, pp. 1224–1235, 2012. View at Publisher · View at Google Scholar